|
Volumn 3, Issue 6, 2012, Pages 659-662
|
Discovery of novel morpholino-quinoxalines as PI3Kα inhibitors by pharmacophore-based screening
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 MORPHOLINO 3 PHENYLSULFONYLQUINOXALINE;
2 MORPHOLINO 3 PHENYLTHIOQUINOXALINE;
2 MORPHOLINO 8 PHENYLCHROMONE;
2 PIPERIDINYL 3 PHENYLSULFONYLQUINOXALINE;
MORPHOLINE DERIVATIVE;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PHOSPHOINOSITIDE 3 KINASE ALPHA;
QUINOXALINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL LINE;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
MOLECULAR DOCKING;
PHARMACOPHORE;
PRIORITY JOURNAL;
|
EID: 84865051335
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c2md00255h Document Type: Article |
Times cited : (18)
|
References (14)
|